Related Experiment Video

Updated: Aug 25, 2025

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

2.2K

The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth

Elizabeth Proaño-Pérez1,2,3, Eva Serrano-Candelas1,2,4, Alfonso García-Valverde5

  • 1Biochemistry and Molecular Biology Unit, Biomedicine Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Cancer Gene Therapy
|October 14, 2022
PubMed

Insights

Microphthalmia-associated transcription factor (MITF) drives gastrointestinal stromal tumor (GIST) growth by regulating KIT signaling. Silencing MITF reduces GIST cell viability, increases apoptosis, and impairs tumor growth, identifying MITF as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal stromal tumors (GISTs) commonly arise from KIT or PDGFRA receptor activation.
  • Key intermediates in the KIT/PDGFRA transforming pathway in GIST remain largely unidentified.
  • Previous work implicated SH3BP2 in GIST cell survival via co-regulation of KIT and Microphthalmia-associated transcription factor (MITF).

Purpose of the Study:

  • To investigate the role of MITF as a novel driver in the KIT transforming program in GIST.
  • To characterize MITF isoforms in GIST cell lines and patient samples.
  • To assess the impact of MITF modulation on GIST cell behavior and tumor growth.

Main Methods:

  • Characterization of MITF isoforms in GIST cell lines and patient samples.
  • Silencing of MITF in GIST cell lines.
  • Assessment of cell viability, apoptosis, cell cycle, and tumor growth in vivo.
  • Analysis of ETV1 expression following MITF silencing.

Main Results:

  • MITF silencing decreased GIST cell viability and increased apoptosis, independent of KIT mutation status.
  • MITF depletion induced cell cycle arrest and inhibited tumor growth in vivo.
  • MITF silencing affected ETV1 expression, a KIT-regulated GIST survival factor.

Conclusions:

  • MITF is a crucial mediator of KIT/PDGFRA oncogenic signaling in GIST.
  • MITF plays a significant role in GIST cell survival and tumor progression.
  • MITF represents a potential therapeutic target for GIST treatment.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K
Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images04:04

Measuring Retinal Vessel Diameter from Mouse Fluorescent Angiography Images

Published on: May 19, 2023

768

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K